期刊文献+

Ecarin测定血浆中凝血酶原的活性 被引量:3

Monitering of Human Plasma Prothrombin Activity with Ecarin
下载PDF
导出
摘要 目的:建立一种准确、快速和灵敏度较高的检测血浆中凝血酶原活性的方法。方法:以巨齿蛇毒中的有效成分Ecarin作为凝血酶原的激活剂,分别采用Ecarin凝固时间法(ECT)和发色底物法测定血浆中的凝血酶原的活性。结果:Earin浓度在1~8 u/ml范围内,随着血浆的稀释,ECT逐渐延长,ECT(lg)和血浆稀释度(lg)之间的相关系数均在-0.943以上,P<0.01;Ecarin浓度(lg)和ECT(lg)的相关系数均在-0.957以上,P<0.01。血浆稀释度为1:50、1:100、1:200、1:400时,Ecarin发色底物法所测血浆稀释度(lg)与A值(lg)之间的相关系数γ=-0.974,P<0.01。结论:Ecarin凝固时间法和发色底物法均具有良好的灵敏度,能较好地反映血浆中凝血酶原活性的变化。 Objective: To develop a highly accurate and sensitive test for the determination of the activity of prothrombin in human plasma. Methods: Ecarin, a protease extracted from Echis carinatus venom, was used as the activator of prothrombin Ecarin clotting times (ECT) and chromogenic substrate method were used. Results: When the concentration of Ecarin was in the range of 1-8u/ml, ECT gradually prolonged with the dilution of the plasma. The correlation(γ) between ECT(lg) and plasma dilution(lg)1: 50, 1:100,1:200, 1:400, the correlation(7) between plasma dilution(lg) and absorption was more than -0. 943, P<0.01; the correlation(γ) between the concentration of Ecarin(lg) and ECT(lg) was more than -0.957,P<0.01. When the dilution of the plasma was (A) was -0. 957, P<0. 01. Conclusion: Both the ECT and chromogenic substrate method were all sensitive to determine the activity of prothrombin in plasma.
出处 《血栓与止血学》 2002年第3期113-114,117,共3页 Chinese Journal of Thrombosis and Hemostasis
基金 国家自然科学基金(39830180)
关键词 Ecarin 血浆 凝血酶原 凝固时间法 发色底物法 Ecarin Plasma Prothrombin
  • 相关文献

参考文献9

  • 1[1]Butenas S, van Veer C, Kenneth G. Mann " Normal" Thrombin Generation Blood, 1999,94:2169-2178.
  • 2[2]Bertina RM, vanTilburg NH, de Fouw, NJ, etal. Thrombin, alink between coagulation activation and fibrinolysis. Ann NY Acad Sci,1992,667: 239-248.
  • 3[3]Galvani M, Ferrini D, Ottani F, et al. Early risk stratification of unstable angina/non-Q myocardial infarction: biochemical markers of coronary thrombosis. Int J Cardiol, 1999,68(Suppl 1 ) :55-61.
  • 4[4]Giannitsis E, Bardorff MM, Schweikart S, etal. Relationship of cardiac troponin T and procoagulant activity in unstable angina. Thromb Haemost, 2000,83: 224-228.
  • 5[6]Komalik F, Blomback B. Prothrombin activation induced by Ecarin-a prothrombin converting enzyme from Echis carinatus venom. Thromb Res, 1975,6: 57 -63.
  • 6[7]Nowak G, Bucha E. Prothrombin conversion intermediate effectively neutralizes toxic levels of hirudin. Thromb Res, 1995,80: 317-325.
  • 7[8]Potzsch B, Hund S, Madlener K, et al. Monitoring of recombinat rirudin: assessment of a plasma-based ecarin clotting time assay.Thromb Res, 1997,86: 373-383.
  • 8[9]Kornalik F. Prothrombin converting-and fibrinolytic effects of ecarin.Czech Med, 1985,8: 51-54.
  • 9[10]Nowak G, Bucha E. Quantitative determination of hirudin in blood and body fluids. Semin Thromb Hemost, 1996,22:197-202.

同被引文献9

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部